OncoPharm

Latest Episodes:

Sneaky TKI Toxicities Aug 12, 2021

Show notes

A recent patient experience serves as a reminder than TKIs, like cabozantinib, can produce many "minor" toxicities that can really add up and affect QOL.

Acala V. Ibrutinib(again) & VidazaAllo Aug 05, 2021

Show notes

Two recent publications to discuss: 1. The publication of a study discussed on our ASCO '21 Pod on acalabrutinib vs. ibrutinib and patient implications (https://ascopubs.org/doi/pdf/10.1200/JCO.21.01210) 2. A good illustration of the "crossing of the curves" and interpreting Kaplan-Meier curves using alloHSCT vs. 5-aza in MDS patients. https://ascopubs.org/doi/pdf/10.1200/JCO.20.02724

Breast Cancer & cGVHD Updates Jul 29, 2021

Show notes

Two breast cancer updates (pembrolizumab in TNBC and adjuvant AI duration) and two cGVHD updates (belumosudil and ruxolitinib).

GOG-172 (IP chemotherapy in ovarian cancer) Jul 22, 2021

Show notes

The almost-award winning* Landmarks in OncoPharm series returns to discuss the landmark Armstrong et al 2006 NEJM paper on using intraperitoneal chemotherapy in stage III ovarian cancer. Link: https://www.nejm.org/doi/full/10.1056/nejmoa052985 *not really

Advertising Amateur Hour Jul 15, 2021

Show notes

A case study in misbranding promotional materials and how to help FDA regulate them.

Capecitabine Jul 08, 2021

Show notes

Foundations of OncoPharm: capecitabine

Hormonal Toxicity Management In Breast Cancer Pts Jul 01, 2021

Show notes

A foundational topic in oncology - managing toxicities of tamoxifen and AI's in breast cancer patients. An excellent evidence-based review was recently published, and is worth our time on the Pod. Link: https://doi.org/10.1016/S1470-2045(20)30666-5

EA1131 & TOURMALINE Jun 24, 2021

Show notes

So-called negative trials still offer information. We discuss ECOG-ACRIN EA1131 in breast cancer and TOURMALINE-MM1 in myeloma in this epidose. EA1131: https://ascopubs.org/doi/pdf/10.1200/JCO.21.00976 TOURMALINE-MM1 (final OS analysis): https://ascopubs.org/doi/pdf/10.1200/JCO.21.00972

Why Learning Oncology Is Hard Jun 18, 2021

Show notes

Why is learning oncology so hard? To get the students perspective I ask a few pharmacy students why in hopes of learning how to better teach and precept oncology trainees.

ASCO 2021 Jun 10, 2021

Show notes

Highlighting results presented at ASCO's 2021 annual meeting.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected